Gastrointestinal Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts up to 2023 - PowerPoint PPT Presentation

Loading...

PPT – Gastrointestinal Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts up to 2023 PowerPoint presentation | free to download - id: 895c54-ZTU4Y



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Gastrointestinal Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts up to 2023

Description:

The report on Gastrointestinal Drugs Market by category(acid neutralizers, antidiarrheal & laxatives, anti-inflammatory), route of administration(oral, parenteral, rectal), disease type(gastro-esophageal reflux disorder, inflammatory bowel disease) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Gastrointestinal Drugs Market is projected to grow at a CAGR between 4.5 % to 5.0% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market. – PowerPoint PPT presentation

Number of Views:15
Slides: 7
Provided by: bondallen78
Category: Other

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Gastrointestinal Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts up to 2023


1
Gastrointestinal Drugs Market Global Industry
Analysis, Trends, Market Size Forecasts up to
2023
2
The report on Gastrointestinal Drugs Market by
category(acid neutralizers, antidiarrheal
laxatives, anti-inflammatory), route of
administration(oral, parenteral, rectal),
disease type(gastro-esophageal reflux disorder,
inflammatory bowel disease) trends analysis and
forecasts up to 2023 studies the market sizes,
key trends and opportunities in the main
geographies such as North America, Europe,
Asia-Pacific, Rest of the World. According to
the report the Global Gastrointestinal Drugs
Market is projected to grow at a CAGR between
4.5 to 5.0 in terms of value over the period of
2017-2023. The
growth in the world market is primarily driven by
significant
contribution by North America (Leading region)
region to this market. Get a Sample Request-
https//www.infiniumglobalresearch.com/Reports/Mak
eSampleRequest/768
Market Insights Global gastrointestinal drugs
market experienced progressive growth over the
past few years. As per the report published by
world gastrointestinal organization in 2015,
almost 35-40 of worlds population is suffering
from acute and chronic gastrointestinal
complications. This includes gastrointestinal
disease and disorder, due to change and dietary
pattern, which is predominantly responsible for
global growth of this market. Moreover, rising
prevalence of gastrointestinal disease across the
globe is equally drives global growth.
Increasing investment in research and development
3
activities in older to develop new drugs along
with growing awareness pertaining to
availability of these treatments have raised
considerable demand for GI drugs. Apart from
this, technological reforms in the treatment
offers superior outputs and expected to
contribute significantly in the forthcoming
years. The exact cause of GI related disorders
are still unknown, due to which cure for these
disorders is not available. This
may hamper global
growth of gastrointestinal drugs market by invitin
g various
complications. Global gastrointestinal market
will have numerous growth opportunities during
the forecasted period on account of
technological advancement, significant unmet need
for novel, safe and effective treatments and
increasing geriatric population that highly
susceptible to the gi disorders.
Segments Covered The report segments the global
gastrointestinal drugs market by drug category,
by route of administration, by disease type, by
end user and by region. The market size of each
segment has been provided in terms of value
(USD). Market segmentation based on type of
drugs category includes acid neutralizers,
antidiarrheal and laxatives, antiemetic,
anti-inflammatory, and others. Wherein acid
neutralizers further sub segmented into
antacids, H2 antagonists, and proton pump
inhibitor. On the basis of route of
administration global market has been segmented
into oral, parenteral, and rectal.
4
Moreover, market based on disease type includes
gastro-esophageal reflux disorder (gerd),
inflammatory bowel disease, and other, whereas,
end user segment comprises hospital pharmacies,
retail pharmacies and other. Make an Enquiry-
https//www.infiniumglobalresearch.com/Reports/Mak
eEnquiryRequest/768 Geographic Coverage and
Analysis The report provides regional analysis
covering geographies such as North America,
Europe, Asia-Pacific, and Rest of the World. In
this section the key trends and market size for
each geography is provided over the period of
2017 2023.
North America is the largest market for
gastrointestinal drugs market, by having over
40 of global markets shares in 2016. The region
anticipated to continue its dominance throughout
the forecasted period. Moreover, U.S. and Mexico
collectively drives the North American
gastrointestinal market by contributing in the
majority regional growth. Rising geriatric
population base in the North America is the key
driving factor in this region along with
consumer friendly reimbursement policies for the
treatment of chronic disease. Europe is the
second largest market followed by Asia Pacific is
at third
5
place, both of these region almost acquired
almost same market shares. Asia Pacific expected
to emerge as most lucrative market over the
forthcoming years. Improved medical and
healthcare infrastructure, rise in public and
private investment in life science research,
technological advancements in the treatment of GI
diseases in emerging economies have made this
region favorable and to grow at highest
CAGR. Companies Profiled The companies covered
in the report include Abbott Laboratories,
Allergan Plc, AstraZeneca, Bayer AG, Boehringer
Ingelheim GmbH, GlaxoSmithKline Plc., Janssen
Biotech Inc., Sanofi, Takeda Pharmaceutical, and
Valeant Pharmaceuticals Inc. Click the Below
Full Report- https//www.infiniumglobalresearch.c
om/healthcare_medical_devices/global_gastroi
ntestinal_drugs_market Report Highlights The
report provides deep insights on demand
forecasts, market trends and micro and macro
indicators. In addition, this report provides
insights on the factors that are driving and
restraining the demand of gastrointestinal drugs
globally as well as regionally.
6
Moreover, IGR-Growth Matrix analysis given in the
report brings an insight on the investment areas
that existing or new market players can
consider. The report provides insights into the
market using analytical tools such as Porters
five forces analysis and DRO analysis of
gastrointestinal drugs. Moreover, the study
highlights current market trends and provides
forecast from 2017 to 2023. We also have
highlighted future trends in the gastrointestinal
drugs Market that will impact the demand during
the forecast period. Moreover, the competitive
analysis given in each regional market brings an
insight on the market share of the leading
players. Additionally, the analysis highlights
rise and fall in the market shares of the key
players in the market. This report will help
manufacturers, suppliers and distributors of the
gastrointestinal drugs market to understand the
present and future trends in this market and
formulate their strategies accordingly.
About PowerShow.com